In one of our most in-depth interviews to date, we spoke with Dr Arnab Basu, CEO of AIM-listed Kromek Group Plc #KMK.
Kromek Group operate in the medical imaging, nuclear detection, and security screening environments and have announced significant contract wins throughout 2017 to the financial markets.
We delve deep in to what it is that is driving company growth and asked how they are going about it by reflecting on recent board appointments, director share purchases, and the ongoing support from institutional backers.
Thank you to Dr Basu for providing such depth and we welcome any feedback on this podcast that investors (or potential investors) may have to email@example.com
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned